Regional Regulation Expert to Cover Drug Serialization and Traceability in India
MUMBAI, India and PRINCETON, New Jersey, Oct. 3, 2016 /PRNewswire/ -- Hemant Koshia, PhD, Commissioner of the Food & Drugs Control Administration for the State Government of Gujarat, India, will
The event will be hosted by Systech International, the global leader in serialization, track-and-trace, and regulatory compliance. Systech's one-day conference will provide customers, industry leaders, and equipment manufacturers with a firm understanding of the many complex regulatory mandates that are quickly unfolding in India and around the world, as well as effective technologies to meet those demands. The event will take place October 6, 2016 at the ITC Maratha Hotel in Mumbai.
Dr. Koshia plays a key role in regulatory policy and advocacy in India and international markets, having recently chaired the Task Force to advise the Ministry of Health and Family Welfare on the optimal path to rolling out a national consumer protection program against the menace of counterfeit drugs. Dr. Koshia has 30 years of experience in regulatory affairs through his work in both government and industry. He spearheaded the implementation of e-governance in the State of Gujarat — the first state in India to do so — and has conceptualized and steered the DMLA/iDMLA project. As a passionate advocate of consumer safety, Dr. Koshia has implemented several major initiatives in his state in this regard.
"Dr. Koshia's lecture will provide further insight into the critical elements that must be considered for the development of a successful domestic anti-counterfeiting program, drawing from field experiences in the enforcement process," notes Avi Chaudhuri, PhD, senior partner, Systech.
The State FDA Commissioners, along with their departmental inspectors and colleagues, operate at the front lines in the fight against counterfeit medicines and routinely report on the interdiction efforts that take place across the country. The development of a domestic plan for consumer protection against counterfeit drugs has recently gathered significant momentum and been aided by the contributions of various State regulators.
The effectiveness of any national program is measured by the reductive impact it has on criminal activity in the sector and the overall health and wellness benefits it brings to the Indian people. Dr. Koshia will share perspectives from the State of Gujarat in his lecture. Additionally, there will be a discussion of best practices evidenced at the State and local levels, along with interesting anecdotes and case studies from actual events.
Register for UNIQUITY India at http://systechone.com/uniquity2016in/.
About Systech International
Systech is the global technology leader in product safety, and consumer and brand protection. Systech pioneered serialization and is defining the future of authentication.
The world's largest pharmaceutical companies trust their brands to Systech's technology solutions. Systech unifies and optimizes enterprise serialization, track and trace, and authentication technologies to ensure regulatory compliance, mitigate risk, and drive efficiency and profitability.
For 30 years, Systech's innovation has led best practices for key brands across the pharmaceutical, life science, food and beverage, and consumer packaged goods industries.
Ann WilletsUS PR for Systech International+1 (908) 433-7821aw@26FIVE.com
Kartick Jagtap/Ninad VardamIndia PR for Systech International+91 22 email@example.com firstname.lastname@example.org
Erin DunkelVice President, Marketing+1 (610) 761-8960Erin.Dunkel@systechone.com
Harry Saint-PreuxDirector, Global Alliances & Channels+1 (201) 923-0726Harry.Saint-Preux@systechone.com
Avi Chaudhuri, PhDSenior Global Partner+91 98 303 65993Avi.Chaudhuri@systechone.com
This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com
Subscribe to our Free Newsletters!
Acute coronary syndrome (ACS) is a sudden, acute life-threatening condition caused by a dramatic ...
Sclerotherapy is a procedure used to treat spider veins, varicose veins and hemorrhoids by directly ...
HELLP syndrome is a rare but serious complication that affects pregnant women. If detected on time, ...View All